BeOne Medicines Ltd. (ONC)
Nasdaq: ONC · Pharmaceutical Preparations · Basel · filing with the SEC since 2015
Who runs BeOne Medicines Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Oyler John
Chief Executive Officer. First filing Feb 2016, latest Aug 12, 2026, 69 filings in all.
Officers reporting now
6
of 22 people with a filing in the last fifteen months
Directors reporting now
16
38 people on the record since 2016
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ball Titus B. | Principal Accounting Officer | Mar 2024 | Nov 10, 2026 | 7 · $800,000 |
| Lee Chan Henry | SVP, General Counsel | Jun 2023 | Nov 9, 2026 | 21 · $5.1M |
| Wu Xiaobin | President and COO | Apr 2018 | Aug 27, 2026 | 19 · $8.8M |
| Oyler John | Chief Executive Officer | Feb 2016 | Aug 12, 2026 | 121 · $328M |
| Rosenberg Aaron | Chief Financial Officer | Jul 2024 | Aug 5, 2026 | 2 · $500,000 |
| Wang Lai | President, Global Head of R&D | Apr 2021 | Jun 25, 2026 | 5 · $1.2M |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Wang Xiaodong | director | Feb 2016 | Nov 12, 2026 | 34 · $46.8M |
| 667, L.P. | director | Feb 2016 | Sep 16, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | Feb 2016 | Sep 16, 2026 | none |
| Baker Bros. Advisors LP | director | Feb 2016 | Sep 16, 2026 | 4 · $300,000 |
| Baker Brothers Life Sciences LP | director | Feb 2016 | Sep 16, 2026 | none |
| Baker Felix | director | Feb 2016 | Sep 16, 2026 | none |
| Baker Julian | director | Feb 2016 | Sep 16, 2026 | none |
| Brandicourt Olivier | director | Jan 2024 | Jun 15, 2026 | none |
| Dugan Margaret | director | Feb 2022 | Jun 15, 2026 | 1 · $100,000 |
| Hooper Anthony C | director | Jan 2020 | Jun 15, 2026 | none |
| Mooney Elizabeth Fisher | director | Jun 2026 | Jun 15, 2026 | none |
| Riva Alessandro | director | Feb 2022 | Jun 15, 2026 | 1 · $100,000 |
| Sawyers Charles Lazelle | director | Jun 2026 | Jun 15, 2026 | none |
| Sharp Shalini | director | Sep 2024 | Jun 15, 2026 | none |
| Yi Qingqing | director | Feb 2016 | Jun 3, 2026 | 1 · $100,000 |
| Sanders Corazon (Corsee) D. | director | Aug 2020 | May 27, 2026 | 3 · $1.0M |
Earlier names on the record26, newest filing first
Hhlr Advisors, Ltd. · 10% owner · last filing Dec 2024Hillhouse Capital Management, Ltd. · 10% owner · last filing Dec 2024Wang Julia Aijun · officer · last filing Jul 2024Glazer Donald W. · director · last filing Jun 2024Malley Thomas · director · last filing Jun 2023Huang Jane · officer · last filing Dec 2021Amgen Inc · 10% owner · last filing Sep 2021Liang Howard · officer · last filing Jun 2021Chen Timothy Yung-Cheng · director · last filing Jun 2021Su Jingshyh S · director · last filing Jun 2021Peterson Amy C. · officer · last filing Dec 2018Li Ji · officer · last filing Mar 201814159, L.P. · director · last filing Oct 2017Tang Ke · director · last filing Apr 2017Yan Wendy Xiaojun · officer · last filing Jul 2016Yang Jianxin · officer · last filing Jul 2016Merck & Co., Inc. · 10% owner · last filing Feb 2016Merck Sharp & Dohme Corp. · 10% owner · last filing Feb 2016Merck Sharp & Dohme Research Gmbh · 10% owner · last filing Feb 2016Yuan Ruirong · officer · last filing Feb 2016Cb Biotech Investment Ltd · 10% owner · last filing Feb 2016Citic Pe Associates, L.P. · 10% owner · last filing Feb 2016Citic Pe Funds Ltd · 10% owner · last filing Feb 2016Cpechina Fund, L.P. · 10% owner · last filing Feb 2016Goller Michael · director · last filing Feb 2016Krishana Ranjeev · director · last filing Feb 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.